Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
GE HealthCare Acquires Intelerad for $2.3 Billion to Accelerate Outpatient Care Growth
The purchase is aimed at strengthening GE’s position in the rapidly expanding outpatient care market.
- By Newsdesk
- New Delhi
- Nov 23, 2025
GE HealthCare has announced a major strategic move with the acquisition of Intelerad, a Montreal-based developer of cloud medical imaging software, in a deal valued at approximately $2.3 billion in cash. The purchase is aimed at strengthening GE’s position in the rapidly expanding outpatient care market.
The deal gives GE HealthCare access to Intelerad’s advanced SaaS imaging platform, widely used by outpatient clinics and diagnostic centres. The acquisition complements GE’s traditional hospital-focused equipment portfolio and positions the company to tap into what it identifies as a “$2 billion-plus” global opportunity in outpatient enterprise imaging.
Market analysts say the acquisition is well aligned with GE HealthCare’s long-term strategy, calling it a smart “tuck-in” that builds on the company’s established capabilities. GE expects the transaction to boost revenue growth and expand margins, projecting a high single-digit return on invested capital within five years.
Intelerad, which has been recording low double-digit annual growth, is projected to generate around $270 million in revenue in its first full year after integration. The acquisition is expected to close in the first half of 2026, pending regulatory approvals, and will mark a full exit for major investors Hg Capital and TA Associates.
With this move, GE HealthCare is doubling down on its shift toward recurring-revenue software solutions and innovation in outpatient care, signalling a significant evolution in its global growth strategy.